Latest News

Latest News

We believe that patients can lead the change in the healthcare system for the first time. We also believe that empowered patients should have a large-scale patient-centred solution that provides evidence-based product recommendations and allows them to collect their own data. This is where the Reformulary Group comes in: Cannabis Standard is one-part formulary and one-part research platform. Our vision is “smart drug and medical cannabis choices” where one day every consumer will rely on our evidence-based tools to make smart choices.

Newsletter

Cannabis Standard Insights
Reformulary Group launches its Cannabis Standard Insights newsletter.
Download Newsletter

News

Canada’s first evidence-based medical cannabis formulary launches today
GLOBENEWSWIRE
Read more

News

Spectrum Cannabis joins Cannabis Standard - the evidence-based medical cannabis formulary for consum...
NEWSWIRE
Read more

News

Starseed joins Cannabis Standard™ for Canadians, employers, physicians
GLOBENEWSWIRE
Read more

News

Reformulary Group signs Aphria to provide medical cannabis for employer plans
GLOBENEWSWIRE
Read more

News

Reformulary Group signs MedReleaf as first Licensed Producer for new medical cannabis formulary
GLOBENEWSWIRE
Read more

News

Expert group to review evidence for use of medical cannabis for employer plans
GLOBENEWSWIRE
Read more